Pharma & Biotech

The landscape of cancer diagnostics is undergoing a profound transformation, with Exact Sciences emerging as a pivotal innovator. The company's...

Cellectar Biosciences has achieved a critical regulatory milestone that could pave the way for European commercialization of its cancer therapeutic...

Bruker Corporation witnessed a substantial uptick in its share price following the announcement of significant new contract awards. Investor sentiment...

ImmunityBio finds itself at a pivotal moment, with groundbreaking clinical achievements coinciding with significant financial improvements. The biotechnology firm's recent...

In a significant pharmaceutical industry development, Pfizer has emerged victorious from a competitive bidding process, successfully acquiring specialist firm Metsera...

After an extended period of lateral trading, shares of biotechnology firm Ocugen are attracting renewed market interest. The catalyst appears...

The obesity treatment sector is experiencing unprecedented consolidation activity, with Viking Therapeutics shares attracting significant speculative interest following Pfizer's recent...

Shares of Plus Therapeutics experienced significant upward momentum in today's trading session, propelled by a combination of revised analyst projections...

The investment community finds itself sharply divided over Danish pharmaceutical leader Novo Nordisk. Conflicting assessments from major financial institutions have...

While Danaher's stock has faced headwinds in the current year, the biotechnology conglomerate is making strategic moves that could redefine...